Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q56783216
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000159.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q56783216
|
024
|
|
|
‡a
0000-0002-2037-8946
‡2
orcid
|
024
|
|
|
‡a
52564361600
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q56783216
|
100
|
0 |
|
‡a
Fernando Souza-Fonseca-Guimaraes
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Fernando Souza-Fonseca-Guimaraes
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
|
670
|
|
|
‡a
Author's A new checkpoint for Natural Killer cell activation.
|
670
|
|
|
‡a
Author's A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
|
670
|
|
|
‡a
Author's Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity
|
670
|
|
|
‡a
Author's Bench to bedside: NK cells and control of metastasis.
|
670
|
|
|
‡a
Author's Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
|
670
|
|
|
‡a
Author's Brown spider (Loxosceles intermedia) venom triggers endothelial cells death by anoikis
|
670
|
|
|
‡a
Author's CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis.
|
670
|
|
|
‡a
Author's CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells
|
670
|
|
|
‡a
Author's Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival
|
670
|
|
|
‡a
Author's Context-Dependent Role for T-bet in T Follicular Helper Differentiation and Germinal Center Function following Viral Infection
|
670
|
|
|
‡a
Author's Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
|
670
|
|
|
‡a
Author's DNAM-1 expression marks an alternative program of NK cell maturation.
|
670
|
|
|
‡a
Author's Effectiveness of Vernonia scorpioides ethanolic extract against skin inflammatory processes
|
670
|
|
|
‡a
Author's Granzyme M has a critical role in providing innate immune protection in ulcerative colitis
|
670
|
|
|
‡a
Author's GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
|
670
|
|
|
‡a
Author's IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection
|
670
|
|
|
‡a
Author's Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.
|
670
|
|
|
‡a
Author's Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β
|
670
|
|
|
‡a
Author's Molecular insight into targeting the NK cell immune response to cancer
|
670
|
|
|
‡a
Author's Myeloid TGF-β responsiveness promotes metastases
|
670
|
|
|
‡a
Author's Natural Killer Cell Assessment in Peripheral Circulation and Bronchoalveolar Lavage Fluid of Patients with Severe Sepsis: A Case Control Study
|
670
|
|
|
‡a
Author's NK cell heparanase controls tumor invasion and immune surveillance
|
670
|
|
|
‡a
Author's NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis
|
670
|
|
|
‡a
Author's NK cells require IL-28R for optimal in vivo activity
|
670
|
|
|
‡a
Author's Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line
|
670
|
|
|
‡a
Author's Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures
|
670
|
|
|
‡a
Author's Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection‡.
|
670
|
|
|
‡a
Author's Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes
|
670
|
|
|
‡a
Author's The Antitumor Effect of Heparin is not Mediated by Direct NK Cell Activation
|
670
|
|
|
‡a
Author's The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
|
670
|
|
|
‡a
Author's The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
|
670
|
|
|
‡a
Author's Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
|
670
|
|
|
‡a
Author's Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
|
909
|
|
|
‡a
(orcid) 0000000220378946
‡9
1
|
909
|
|
|
‡a
(scopus) 52564361600
‡9
1
|
919
|
|
|
‡a
anticd137enhancesanticd20therapyofsystemicbcelllymphomawithalteredimmunehomeostasisbutnegligibletoxicity
‡A
Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity
‡9
1
|
919
|
|
|
‡a
blockadeofthecoinhibitorymoleculepd1unleashesilc2dependentantitumorimmunityinmelanoma
‡A
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
‡9
1
|
919
|
|
|
‡a
brownspiderloxoscelesintermediavenomtriggersendothelialcellsdeathbyanoikis
‡A
Brown spider (Loxosceles intermedia) venom triggers endothelial cells death by anoikis
‡9
1
|
919
|
|
|
‡a
cd24triggeredcaspasedependentapoptosisviamitochondrialmembranedepolarizationandreactiveoxygenspeciesproductionofhumanneutrophilsisimpairedinsepsis
‡A
CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis.
‡9
1
|
919
|
|
|
‡a
cd3brightsignalsonγδtcellsidentifyil17aproducingvγ6vδ1+tcells
‡A
CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells
‡9
1
|
919
|
|
|
‡a
cellcycleprogressiondictatestherequirementforbcl2innaturalkillercellsurvival
‡A
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival
‡9
1
|
919
|
|
|
‡a
contextdependentrolefortbetintfollicularhelperdifferentiationandgerminalcenterfunctionfollowingviralinfection
‡A
Context-Dependent Role for T-bet in T Follicular Helper Differentiation and Germinal Center Function following Viral Infection
‡9
1
|
919
|
|
|
‡a
discretetissuemicroenvironmentsinstructdiversityinresidentmemorytcellfunctionandplasticity
‡A
Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
‡9
1
|
919
|
|
|
‡a
dnam1expressionmarksanalternativeprogramofnkcellmaturation
‡A
DNAM-1 expression marks an alternative program of NK cell maturation.
‡9
1
|
919
|
|
|
‡a
effectivenessofvernoniascorpioidesethanolicextractagainstskininflammatoryprocesses
‡A
Effectiveness of Vernonia scorpioides ethanolic extract against skin inflammatory processes
‡9
1
|
919
|
|
|
‡a
granzyme1000hasacriticalroleinprovidinginnateimmuneprotectioninulcerativecolitis
‡A
Granzyme M has a critical role in providing innate immune protection in ulcerative colitis
‡9
1
|
919
|
|
|
‡a
gvhdpreventsnkcelldependentleukemiaandvirusspecificinnateimmunity
‡A
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
‡9
1
|
919
|
|
|
‡a
ifnar1signallingobstructsicosmediatedhumoralimmunityduringnonlethalbloodstageplasmodiuminfection
‡A
IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection
‡9
1
|
919
|
|
|
‡a
innateimmunodeficiencyfollowinggeneticablationofmcl1innaturalkillercells
‡A
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.
‡9
1
|
919
|
|
|
‡a
lossoffunctioninsmad4mightnotbecriticalforhumannaturalkillercellresponsivenesstotgfβ
‡A
Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β
‡9
1
|
919
|
|
|
‡a
molecularinsightintotargetingthenkcellimmuneresponsetocancer
‡A
Molecular insight into targeting the NK cell immune response to cancer
‡9
1
|
919
|
|
|
‡a
myeloidtgfβresponsivenesspromotesmetastases
‡A
Myeloid TGF-β responsiveness promotes metastases
‡9
1
|
919
|
|
|
‡a
naturalkillercellassessmentinperipheralcirculationandbronchoalveolarlavagefluidofpatientswithseveresepsisacasecontrolstudy
‡A
Natural Killer Cell Assessment in Peripheral Circulation and Bronchoalveolar Lavage Fluid of Patients with Severe Sepsis: A Case Control Study
‡9
1
|
919
|
|
|
‡a
nkcellheparanasecontrolstumorinvasionandimmunesurveillance
‡A
NK cell heparanase controls tumor invasion and immune surveillance
‡9
1
|
919
|
|
|
‡a
nkcelltolerancetotlragonistsmediatedbyregulatorytcellsafterpolymicrobialsepsis
‡A
NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis
‡9
1
|
919
|
|
|
‡a
nkcellsrequireil28rforoptimalinvivoactivity
‡A
NK cells require IL-28R for optimal in vivo activity
‡9
1
|
919
|
|
|
‡a
pravastatininducescellcyclearrestanddecreasedproductionofvegfandbfgfinmultiplemyelomacellline
‡A
Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line
‡9
1
|
919
|
|
|
‡a
profilingoflungsarscov2andinfluenzavirusinfectiondissectsvirusspecifichostresponsesandgenesignatures
‡A
Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures
‡9
1
|
919
|
|
|
‡a
rapidlossofgroup1innatelymphoidcellsduringbloodstageplasmodiuminfection
‡A
Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection‡.
‡9
1
|
919
|
|
|
‡a
recipientbcl2inhibitionandnkcellablationformpartofareducedintensityconditioningregimethatimprovesallobonemarrowtransplantationoutcomes
‡A
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes
‡9
1
|
919
|
|
|
‡a
antitumoreffectofheparinisnotmediatedbydirectnkcellactivation
‡A
The Antitumor Effect of Heparin is not Mediated by Direct NK Cell Activation
‡9
1
|
919
|
|
|
‡a
emergenceofnaturalkillercellsasamajortargetincancerimmunotherapy
‡A
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
‡9
1
|
919
|
|
|
‡a
receptorscd96andcd226opposeeachotherintheregulationofnaturalkillercellfunctions
‡A
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
‡9
1
|
919
|
|
|
‡a
therapeuticblockadeofactivinaimprovesnkcellfunctionandantitumorimmunity
‡A
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
‡9
1
|
919
|
|
|
‡a
tumorimmunoevasionbytheconversionofeffectornkcellsintotype1innatelymphoidcells
‡A
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
‡9
1
|
919
|
|
|
‡a
benchtobedsidenkcellsandcontrolofmetastasis
‡A
Bench to bedside: NK cells and control of metastasis.
‡9
1
|
919
|
|
|
‡a
genesignaturepredictingnaturalkillercellinfiltrationandimprovedsurvivalinmelanomapatients
‡A
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
‡9
1
|
919
|
|
|
‡a
newcheckpointfornaturalkillercellactivation
‡A
A new checkpoint for Natural Killer cell activation.
‡9
1
|
919
|
|
|
‡a
novelimmunogenicmousemodelofmelanomaforthepreclinicalassessmentofcombinationtargetedandimmunebasedtherapy
‡A
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
SUDOC|167142348
|
996
|
|
|
‡2
LC|no2012151771
|
996
|
|
|
‡2
ISNI|0000000395731027
|
996
|
|
|
‡2
ISNI|0000000067997176
|
996
|
|
|
‡2
CAOONL|ncf11189804
|
996
|
|
|
‡2
SUDOC|050268155
|
996
|
|
|
‡2
PTBNP|961808
|
996
|
|
|
‡2
DNB|1057275239
|
996
|
|
|
‡2
PTBNP|1015963
|
996
|
|
|
‡2
DNB|1147173311
|
996
|
|
|
‡2
BLBNB|001411242
|
996
|
|
|
‡2
LC|n 2004097004
|
996
|
|
|
‡2
NTA|175557012
|
996
|
|
|
‡2
BIBSYS|98057732
|
996
|
|
|
‡2
DNB|1061003078
|
996
|
|
|
‡2
NKC|kup20000000034295
|
996
|
|
|
‡2
DNB|1053086490
|
996
|
|
|
‡2
DNB|172109833
|
996
|
|
|
‡2
NII|DA1097287X
|
996
|
|
|
‡2
PTBNP|41304
|
996
|
|
|
‡2
LC|n 81049629
|
996
|
|
|
‡2
NUKAT|n 2016244027
|
996
|
|
|
‡2
BLBNB|000292711
|
996
|
|
|
‡2
PTBNP|202535
|
996
|
|
|
‡2
PLWABN|9810700080005606
|
996
|
|
|
‡2
DNB|173592341
|
996
|
|
|
‡2
SUDOC|170300560
|
996
|
|
|
‡2
NUKAT|n 2016260112
|
996
|
|
|
‡2
SUDOC|187843546
|
996
|
|
|
‡2
PTBNP|209012
|
996
|
|
|
‡2
PTBNP|1476844
|
996
|
|
|
‡2
LC|n 2023073009
|
996
|
|
|
‡2
ISNI|0000000053086056
|
996
|
|
|
‡2
RERO|A009001562
|
996
|
|
|
‡2
CAOONL|ncf11677618
|
996
|
|
|
‡2
PTBNP|904176
|
996
|
|
|
‡2
DNB|1056327952
|
996
|
|
|
‡2
BNF|16539866
|
996
|
|
|
‡2
BNE|XX1721302
|
996
|
|
|
‡2
BLBNB|000233016
|
996
|
|
|
‡2
NYNYRILM|76064
|
996
|
|
|
‡2
NTA|068715919
|
996
|
|
|
‡2
PTBNP|1890882
|
996
|
|
|
‡2
PTBNP|1589416
|
996
|
|
|
‡2
LC|nr2002034756
|
996
|
|
|
‡2
BIBSYS|90564937
|
996
|
|
|
‡2
RERO|A011630352
|
996
|
|
|
‡2
ISNI|0000000109053043
|
996
|
|
|
‡2
BNF|13492584
|
996
|
|
|
‡2
LC|n 2019053597
|
996
|
|
|
‡2
ISNI|0000000356431523
|
996
|
|
|
‡2
BLBNB|000248418
|
996
|
|
|
‡2
ISNI|0000000069585247
|
996
|
|
|
‡2
ISNI|0000000073206158
|
996
|
|
|
‡2
BLBNB|000233014
|
996
|
|
|
‡2
PTBNP|1463887
|
996
|
|
|
‡2
BLBNB|000222834
|
996
|
|
|
‡2
PLWABN|9810698094905606
|
996
|
|
|
‡2
RERO|A024763968
|
996
|
|
|
‡2
NSK|000675098
|
996
|
|
|
‡2
NYNYRILM|338268
|
996
|
|
|
‡2
ISNI|0000000067810164
|
996
|
|
|
‡2
ISNI|0000000069510894
|
996
|
|
|
‡2
LC|n 85073538
|
996
|
|
|
‡2
ISNI|0000000036223469
|
996
|
|
|
‡2
ISNI|0000000033544291
|
996
|
|
|
‡2
LC|no2002096697
|
996
|
|
|
‡2
BLBNB|000181319
|
996
|
|
|
‡2
NUKAT|n 2007278215
|
996
|
|
|
‡2
NUKAT|n 2008085093
|
996
|
|
|
‡2
BLBNB|000290704
|
996
|
|
|
‡2
LC|n 97016215
|
996
|
|
|
‡2
PTBNP|213828
|
996
|
|
|
‡2
PTBNP|714624
|
996
|
|
|
‡2
PTBNP|1293120
|
996
|
|
|
‡2
SUDOC|028412303
|
996
|
|
|
‡2
PTBNP|988621
|
996
|
|
|
‡2
NII|DA17481854
|
996
|
|
|
‡2
BNF|12025228
|
996
|
|
|
‡2
NSK|000257044
|
996
|
|
|
‡2
ISNI|0000000112048181
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|